Second-Line Liposomal Irinotecan Fails to Improve OS, PFS Over Topotecan in SCLC OncLive, 06 Apr 2023 Image Credit: © Axel Kock - stock.adobe.com Single-agent liposomal irinotecan (Onivyde) resulted in a similar median overall…